This discovery provides the first direct evidence linking ANLN abnormalities to the onset of blood cancers and highlights a mechanistically distinct mode of ANLN activation compared with solid tumors. This evidence concerns the gene ANLN and hematopoietic and lymphoid system neoplasm.